0000899866-19-000011.txt : 20190211
0000899866-19-000011.hdr.sgml : 20190211
20190211181848
ACCESSION NUMBER: 0000899866-19-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190207
FILED AS OF DATE: 20190211
DATE AS OF CHANGE: 20190211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Franchini Indrani Lall
CENTRAL INDEX KEY: 0001708764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 19586972
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS, INC
STREET 2: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 4752302596
MAIL ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960111
4
1
wf-form4_154992711355552.xml
FORM 4
X0306
4
2019-02-07
0
0000899866
ALEXION PHARMACEUTICALS, INC.
ALXN
0001708764
Franchini Indrani Lall
C/O ALEXION PHARMACEUTICALS, INC.
121 SEAPORT BOULEVARD
BOSTON
MA
02210
0
1
0
0
EVP, Chief Compliance Officer
Common Stock, par value $.0001 per share
2019-02-07
4
F
0
1398
119.57
D
27906
D
This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $119.43 - $119.57. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
/s/ Douglas J. Barry, Attorney-in-Fact for Indrani L. Franchini
2019-02-11